- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02670473
Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks
July 18, 2017 updated by: CooperVision, Inc.
The aim of this dispensing study is to evaluate the clinical performance of habitual wearers of enfilcon A lenses following a refit with fanfilcon A lenses over 4 weeks of daily wear.
Study Overview
Detailed Description
This is a 30 subject, prospective, dispensing, bilateral wear, subject-masked study, reviewing the refit characteristics in a group of enfilcon A wearers switched to the fanfilcon A lens.
Subject's habitual enfilcon A lenses will be evaluated at the first vist and then re-fitted with a pair of fanfilcon A lenses for 4 weeks of daily wear.
After the dispensing visit, subjects will return for evaluations at 1 week, 2 weeks, and 4 weeks.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Valencia, Spain, 46100
- Optometry Research Group (GIO) Optics Department, University of Valencia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria
A person is eligible for inclusion in the study if he/she:
- Is between 18 and 40 years of age
- Has had a self-reported visual exam in the last two years
- Is an adapted enfilcon A contact lens wearer (at least 2 weeks in enfilcon A lens)
- Has a contact lens spherical prescription between -1.00 to - 6.00
- Has a spectacle cylinder up to 0.75D (Diopters) in each eye.
- Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
- Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
- Has clear corneas and no active ocular disease
- Has read, understood, and signed the information consent letter.
- Patient contact lens refraction should fit within the available parameters of the study lenses.
- Is willing to comply with the wear schedule (at least 5 days per week, > 8 hours/day assuming there are no contraindications for doing so).
- Is willing to comply with the visit schedule
Exclusion Criteria
A person will be excluded from the study if he/she:
- Is not a habitual wearer of enfilcon A lenses
- Has a CL (Contact Lens) prescription outside the range of the available parameters of the study lenses.
- Has a spectacle cylinder ≥1.00D of cylinder in either eye.
- Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
- Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
- Presence of clinically significant (grade 3-4) anterior segment abnormalities
- Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium, pinguecula, or corneal scars within the visual axis
- Neovascularization > 0.75 mm in from of the limbus
- Giant papillary conjunctivitis (GCP) worse than grade 1
- Anterior uveitis or iritis (past or present)
- Seborrheic eczema, Seborrheic conjunctivitis
- History of corneal ulcers or fungal infections
- Poor personal hygiene
- Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
- Has aphakia, keratoconus or a highly irregular cornea.
- Has Presbyopia or has dependence on spectacles for near work over the contact lenses.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: enfilcon A (habitual)
Participants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.
|
|
|
Experimental: fanfilcon A (test)
Participants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.
|
contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Fit - Centration
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Lens fit evaluation of centration for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale: optimum, decentration acceptable, decentration unacceptable.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Lens Fit - Post-blink Movement
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Lens fit evaluation of post-blink movement for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-5 Likert scale, 0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Lens Tightness on Push-up
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Lens fit evaluation of tightness on push-up test for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale: 0%-100%, 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Overall Fit Acceptance
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Overall fit acceptance for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimum acceptable, early review, 3=Not perfect but okay to dispense, 4=Perfect.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Comfort
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Subjective rating of overall comfort for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-10, 0=could feel, 10=cannot feel.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Dryness Overall
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Subjective rating of overall dryness for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-10, 0=very dry, 10=no dryness.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Handling
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Subjective rating of handling for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-10, 0=very difficult to handle, 10=very easy to handle.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Overall Vision Satisfaction
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Subjective rating of overall vision satisfaction for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-10, 0=very dissatisfied, 10=very satisfied.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Overall Satisfaction
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Subjective rating of overall satisfaction for enfilcon A habitual lens (control) at baseline and fanfilcon A lens (test) at 1 week, 2 weeks, and 4 weeks.
Scale 1-4, 1=completely satisfied, 2=somewhat satisfied, 3=somewhat dissatisfied, 4=completely dissatisfied.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Lens Preference Overall
Time Frame: 1 week, 2 weeks, and 4 weeks
|
Subject's overall preference for one of two contact lenses.
Forced choice: enfilcon A habitual lens (control) or fanfilcon A lens (test).
|
1 week, 2 weeks, and 4 weeks
|
|
Wearing Times
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Average wearing time and comfortable wearing times for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks measured by hours.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Conjunctival Staining
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Conjunctival staining for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
(Scale 0-4, 0.5 steps 0=normal, 4=severe).
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
|
Corneal Staining
Time Frame: Baseline, 1 week, 2 weeks, and 4 weeks
|
Corneal staining for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks.
Scale 0-4, 0.5 steps 0=normal, 4=severe.
|
Baseline, 1 week, 2 weeks, and 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert Montés-Mico, O.D., PhD, Optometry Research Group (GIO) University of Valencia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
January 28, 2016
First Submitted That Met QC Criteria
January 28, 2016
First Posted (Estimate)
February 1, 2016
Study Record Updates
Last Update Posted (Actual)
February 5, 2018
Last Update Submitted That Met QC Criteria
July 18, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-55 (CV-15-09)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on fanfilcon A (test)
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedAstigmatism | Myopia | HyperopiaCanada, United States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedAstigmatismUnited States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed